Volume : 10, Issue : 07, July – 2023

Title:

03.DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF SITAGLIPTIN AND ERTUGLIFLOZIN IN PHARMACEUTICAL DOSAGE FORMS

Authors :

P.Raju *, D.Varun, C. Bharath Chandra, A.Hima Bindu, K.Ganesh, J.Dharmender, R.Suneetha , S.K.Godasu

Abstract :

Another technique was laid out for concurrent assessment of Ertugliflozin and sitagliptin by RP-HPLC strategy. Chromatogram was gone through Inertsil ODS C185m (4.6 x 250mm). Portable stage containing Phosphate support and Acetonitril in the proportion of 30:70 was siphoned through section at a stream pace of 1ml/min. Support utilized at pH 4.6. Temperature was kept up with at Encompassing. Streamlined frequency for Sitagliptin and Ertugliflozin was 235 nm. Maintenance season of Sitagliptin and Ertugliflozin were viewed as 2.395min and 3.906min. The % virtue of Sitagliptin and Ertugliflozin was viewed as 100.6% and 101.3% individually. The framework appropriateness boundaries for Sitagliptin and Ertugliflozin, for example, hypothetical plates and following variable were viewed as 1.3, 1012.4and 1.2, 1848.2 the goal was viewed as 9.0.The linearity study for Sitagliptin and Ertugliflozin was found in fixation scope of 1μg-5μg and 100μg-500μg and relationship coefficient (r2) was viewed as 0.999 and 0.999, % mean recuperation was viewed as 100.1% and 100.4%, %RSD for repeatability was0.31 and 0.38, % RSD for halfway accuracy was 0.12 and 0.15 separately. The accuracy study was exact, powerful and repeatable. LOD esteem was 2.94 and 3.03, and LOQ esteem was 9.87 and 10.1 separately The consequences of study showed that the proposed RP‐HPLC technique is a basic, exact, exact, rough, vigorous, quick and reproducible, which might be valuable for the normal assessment of Ertugliflozin and sitagliptin in drug measurements structure.
Keywords: Ertugliflozin, sitagliptin, RP‐HPLC, Simultaneous estimation.

Cite This Article:

Please cite this article in press : P.Raju et al, Development And Validation Of Stability Indicating RP-HPLC Method For The Simultaneous Estimation Of Sitagliptin And Ertugliflozin In Pharmaceutical Dosage Forms., Indo Am. J. P. Sci, 2023; 10 (07).

Number of Downloads : 10

References:

1. Miao Z, Nucci G, Amin N, Sharma R, Mascitti V, Tugnait M, Vaz AD, Callegari E, Kalgutkar AS: Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects. Drug Metab Dispos. 2013 Feb;41(2):445-56.
2. Herman GA, Bergman A, Liu F, Stevens C, Wang AQ, Zeng W, Chen L, Snyder K, Hilliard D, Tanen M, Tanaka W, Meehan AG, Lasseter K, Dilzer S, Blum R, Wagner JA: Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects. J Clin Pharmacol. 2006 Aug;46(8):876-86.
3. Shafaat SW, Ahmed A, Khan GJ, Anas S and Qureshi AA: Analytical method development and validation for simultaneous estimation of ertugliflozin and metformin HCl in bulk and pharmaceutical dosage form by HPLC. Int J Pharm Sci & Res 2020; 11(1): 226-32.
4. A. Suneetha, V. Mounika, Shaik Mahammad Sajid. Development and Validation of Stability indicating RP-HPLC Method for the simultaneous Estimation of Sitagliptin and Ertugliflozin in bulk and Tablet Dosage Forms. Asian J. Pharm. Ana. 2020; 10(2): 81-85.
5. Bhawani Sunkara, Tulja Rani Gampa, Mounika Markanti1 and Ratna Kumari Midthapally. Stability indicating method development and validation for simultaneous estimation and quantification of Ertugliflozin and Metformin in bulk and tablet dosage form. Future Journal of Pharmaceutical Sciences (2021) 7:32
6. Nizami T., Shrivastava B. and Sharma P. (2018). Analytical method development and validation for simultaneous estimation of Ertugliflozin and Metformin in tablet dosage form by RP-HPLC method. Int. J. Pharm. Life Sci., 9(7):5854-5859
7. Sankar, A S K & Sythana, Suraj & Jhansi, Aakula & Shanmugasundaram, Palani & M, Sumithra. (2015). Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method. International Journal of PharmTech Research. 5.
8. Babu, China & Chetty, C. & Mastanamma, S.. (2018). Novel Stress Indicating RP-HPLC Method Development and Validation for the Simultaneous Estimation of Ertugliflozin and Sitagliptin in Bulk and its Formulation. Oriental Journal of Chemistry. 34. 2554-2561.
9. B, R.k., Addanki, S. Novel stability-indicating RP-UPLC method for simultaneous estimation of sitagliptin and ertugliflozin in bulk and pharmaceutical formulations. Futur J Pharm Sci 7, 86 (2021

</div8